NeurAxis, Inc. (NRXS) Insider Trading Activity

AMEX$6.58
Market Cap
$82.63M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
131 of 849
Rank in Industry
77 of 491

NRXS Insider Trading Activity

NRXS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,051,453
7
100
Sells
$0
0
0

Related Transactions

Aharon Gildirector
1
$1.01M
0
$0
$1.01M
Henrichs Timothy RobertChief Financial Officer
2
$24,257
0
$0
$24,257
Carrico Brian AllenChief Executive Officer
2
$17,095
0
$0
$17,095
Carrico Thomas JoesephCRO, CCO, CPO
2
$2,895
0
$0
$2,895

About NeurAxis, Inc.

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, …

Insider Activity of NeurAxis, Inc.

Over the last 12 months, insiders at NeurAxis, Inc. have bought $1.05M and sold $0 worth of NeurAxis, Inc. stock.

On average, over the past 5 years, insiders at NeurAxis, Inc. have bought $1.05M and sold $652,003 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Aharon Gil (director) — $1.01M. Henrichs Timothy Robert (Chief Financial Officer) — $24,257. Carrico Brian Allen (Chief Executive Officer) — $17,095.

The last purchase of 268 shares for transaction amount of $1,297 was made by Carrico Brian Allen (Chief Executive Officer) on 2026‑10‑08.

List of Insider Buy and Sell Transactions, NeurAxis, Inc.

2026-10-08PurchaseCarrico Brian AllenChief Executive Officer
268
0.0015%
$4.84
$1,297
+9.01%
2026-10-08PurchaseCarrico Thomas JoesephCRO, CCO, CPO
328
0.0019%
$4.84
$1,588
+9.01%
2026-10-08PurchaseHenrichs Timothy RobertChief Financial Officer
1,937
0.0111%
$4.84
$9,375
+9.01%
2026-04-01PurchaseCarrico Brian AllenChief Executive Officer
8,060
0.02%
$1.96
$15,798
-1.39%
2026-04-01PurchaseCarrico Thomas JoesephCRO, CCO, CPO
667
0.0017%
$1.96
$1,307
-1.39%
2026-04-01PurchaseHenrichs Timothy RobertChief Financial Officer
7,593
0.0189%
$1.96
$14,882
-1.39%
2025-12-23PurchaseAharon Gildirector
286,138
2.097%
$3.52
$1.01M
+97.13%
2025-07-01SaleMASIMO CORP10 percent owner
289,779
1.3575%
$2.25
$652,003
+76.89%
Total: 8
*Gray background shows transactions not older than one year

NRXS Institutional Investors: Active Positions

Increased Positions9+42.86%839,216+103.72%
Decreased Positions7-33.33%75,779-9.37%
New Positions5New551,251New
Sold Out Positions5Sold Out62,347Sold Out
Total Postitions23+9.52%2M+94.36%

NRXS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.